Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
William Watson
AddedFeb 15, 2024
UpdatedMay 31, 2026
William Watson

William Watson

Co-Founder, Spectrum Antimicrobials

CrunchbaseLinkedInThe Org

William Watson's Career

Spectrum Antimicrobials
Spectrum Antimicrobials

Petaluma, CA, US

Co-Founder
Collidion
Collidion

Petaluma, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

William Watson's Career

Spectrum Antimicrobials
Spectrum Antimicrobials
Series A$25.9M302016Petaluma, CA, US
Co-Founder

Similar to Spectrum Antimicrobials

ProkaryoticsProkaryoticsUnion, NJ, USAntibioticsest. 2017ProkaryoticsUnion, NJ, US · est. 2017

Prokaryotics: A biopharmaceutical start-up optimizing Merck's early-stage antibiotic programs.

Seed · $2.5M6
Anti-Microbial SolutionsAnti-Microbial SolutionsBedford, NH, USAnti-Microbial, Technologyest. 2008Anti-Microbial SolutionsBedford, NH, US · est. 2008

AMS: Global provider of cost-effective, innovative anti-microbial technology since 2008.

Seed · $1.6M6
MicrobionMicrobionBozeman, MT, USTherapeuticsest. 2000MicrobionBozeman, MT, US · est. 2000

Microbion: Innovating therapeutic solutions for bacterial infections in the pharmaceutical sector.

Series A · $56.4M17
MycologicsMycologicsDurham, NC, USAntimicrobialsest. 2020MycologicsDurham, NC, US · est. 2020

Mycologics: A biotech company developing green antimicrobial solutions for public health and food safety.

Angel · $10k2
Collidion
Collidion
Series B$13.2M122015Petaluma, CA, US
Co-Founder

Leadership at Collidion

Gregg Huber AltonGregg Huber AltonBoard Member
Ettore CarinoEttore CarinoBoard Member
Hoji AlimiHoji AlimiBoard Member

Similar to Collidion

Innovative Trauma CareInnovative Trauma CareSan Antonio, TX, USMedical Devicesest. 2010Innovative Trauma CareSan Antonio, TX, US · est. 2010

Innovative Trauma Care: A medical device company specializing in hemorrhage solutions.

Angel · $12.3M16
CollaMedixCollaMedixCleveland, OH, USMedical Devicesest. 2018CollaMedixCleveland, OH, US · est. 2018

CollaMedix: Providing innovative collagen-based medical devices for women's urinary incontinence.

Pre-Seed · $1.2M9
Blossom InnovationsBlossom InnovationsBoston, MA, USMedical Devicesest. 2011Blossom InnovationsBoston, MA, US · est. 2011

Blossom Innovations: Transforming early-stage scientific ideas into novel medical technologies.

Series A · $9M14
HospiHospiNewark, CA, USMedical Devicesest. 2012HospiNewark, CA, US · est. 2012

Hospi Corp: Innovating high-impact medical devices for enhanced patient comfort and cost reduction.

Series A · $4.8M15

William Watson's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to William Watson

William PedrantiWilliam PedrantiCo-Founder · Scilex Holding CompanyChad KehoeChad KehoeCo-Founder · LeasefulJohn ConnollyJohn ConnollyBoard Member · WIN RealityAdam GassinAdam GassinBoard Member · DispatchTrackSteve LeSieurSteve LeSieurBoard Member · GoodRxMichael RadonichMichael RadonichBoard Member · Spreedly